Tickers: XTSX:EYC, PINX:EYCCF
Vancouver, BC - TheNewswire - September 19, 2019- Eyecarrot Innovations Corp. (TSXV:EYC) is pleased to announce a non-brokered private placement (the "Offering") of up to $2,250,000 on a best efforts basis, through the sale of 15,000,000 units at a price of $0.15 per unit (a "Unit"), each Unit being comprised of one common share and one common share purchase warrant. Each warrant will be exercisable into one common share for a period of 24 months at an exercise price of $0.30 subject to an accelerated conversion such that in the event that the closing price of the Company's shares exceed $0.60 per share for a period of 5 consecutive trading days, at the Company's election, the 24 month period within which the warrants are exercisable will be reduced and the holders of the warrants will have 30 days to exercise.
The Company also intends to complete a portion of the Offering pursuant to Multilateral CSA Notice 45-318 Prospectus Exemption for Certain Distributions through an Investment Dealer ("CSA 45-318") and the corresponding instruments, orders, and rules implementing CSA 45-318 in the participating jurisdictions (collectively with CSA 45- 318, the "Investment Dealer Exemption"). In addition to conducting the Offering pursuant to the Investment Dealer Exemption, the Company will also accept subscriptions for Units where other prospectus exemptions are available.
The Company may pay finder's fees in respect of the Offering, subject to compliance with applicable securities laws and the policies of the TSX Venture Exchange.
The proceeds will be used for the furtherance of the Company's business plan and for working capital purposes.
About Eyecarrot Innovations Corp (EYC)
Eyecarrot is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.
On behalf of the Board of Directors
President | CEO
Toll-free: 1 (844) 866-6162
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2019 TheNewswire - All rights reserved.